Insulet Corporation <PODD.O>: Stifel cuts target price to $180 from $225
PODD•Related News
Mira Pharma reports positive 7-day dog toxicokinetic study results for obesity drug candidate SKNY-1
MIRA•
Edgewise Therapeutics Q2 Operating Income USD -61.943 Million
EWTX•
Quanterix management participates in Canaccord Genuity Growth Conference fireside chat
QTRX•
Kingsoft Cloud to release Q2 2026 results before US market open
KC•
Madrigal Pharmaceuticals to present at Canaccord Genuity Annual Growth Conference
MDGL•